RNAV8 BIO, INC. — Form D/A
RNAV8 BIO, INC. of LAGUNA NIGUEL, CA, a company, filed a Form D amendment with the SEC on 2025-03-17. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-17
- Form: D/A
- Accession: 0001960745-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $986K
- Investors: 42
- Date of first sale: 2022-05-09
- Revenue range: Decline to Disclose
- SEC file number: 021-469573
Issuer
- Name: RNAV8 BIO, INC.
- CIK: 0001960745
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 29851 WEATHERWOOD, LAGUNA NIGUEL, CA, 92677
- Phone: (949) 637-2100
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Devan Shah | Director | Laguna Niguel, CA |
| Devan Shah | Executive Officer | Laguna Niguel, CA |
Other filings by this issuer (3)
More